Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of Eldecalcitol in healthy male volunteers
jRCT2080223085Phase 1Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised trial of eldecalcitol (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoints: Maximum serum concentration (Cmax) of eldecalcitol, Area under the concentration-time curve from 0 to 24 hours (AUC(0–24h)) of eldecalcitol and 1 more. Started Jan 2016; status: completed.
02
Drugs
eldecalcitol
Beyond the preview
Go deeper on jRCT2080223085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223085.